Description: The success of the Pd1 Pdl1 Inhibitors Market is directly linked to their ability to unleash the immune system against cancer. While highly effective, this mechanism means these drugs can also cause a spectrum of immune-related adverse events (irAEs), ranging from mild skin rashes to severe inflammation of vital organs like the lungs, liver, and colon. Effectively managing these...